Theravance Biopharma Newsroom

A Quick Look at Today's Ratings for Theravance Biopharma(TBPH.US), With a Forecast Between $9 to $15

Moomoo NewsNov 14 08:05 ET

Theravance Biopharma (TBPH) Receives a Hold From Evercore ISI

TipRanksNov 13 08:42 ET

H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 13 06:36 ET

Buy Rating Reaffirmed for Theravance Biopharma Amid Positive Momentum and Strategic Initiatives

TipRanksNov 13 06:28 ET

Theravance Biopharma Analyst Ratings

BenzingaSep 16 07:54 ET

H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsSep 16 06:31 ET

HC Wainwright & Co. Maintains Buy on Theravance Biopharma, Lowers Price Target to $15

BenzingaAug 6 15:02 ET

Theravance Biopharma Price Target Cut to $10.00/Share From $15.00 by Leerink Partners

Dow JonesAug 6 09:03 ET

Theravance Biopharma Analyst Ratings

BenzingaAug 6 08:51 ET

Leerink Partners Downgrades Theravance Biopharma(TBPH.US) to Hold Rating, Cuts Target Price to $10

Moomoo NewsAug 6 08:36 ET

Evercore Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Maintains Target Price $11

Moomoo NewsAug 6 08:34 ET

Hold Rating on Theravance Biopharma Amidst Revised Revenue Projections and Pipeline Delays

TipRanksAug 6 08:11 ET

H.C. Wainwright Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsAug 6 06:31 ET

Theravance Biopharma: Hold Rating Maintained Amid Adjusted Sales Expectations and Development Delays

TipRanksAug 5 23:47 ET

Theravance Biopharma Analyst Ratings

BenzingaMay 29 07:02 ET

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Theravance Biopharma (TBPH) and Merus (MRUS)

TipRanksMay 29 06:24 ET

Theravance Biopharma (TBPH) Receives a Hold From TD Cowen

TipRanksMay 24 07:40 ET

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Theravance Biopharma (TBPH)

TipRanksMay 24 05:50 ET

Buy Rating Affirmed on Theravance Biopharma Amid Strong Q1 Performance and Promising Pipeline Prospects

TipRanksMay 16 04:15 ET

Theravance Biopharma Analyst Ratings

BenzingaMay 14 07:34 ET